The program is still filling in: some talks have no title yet and more speakers will be added. We’ll add new sessions, the organizations presenting them and stand numbers once the floor plan is published.

Immunotherapy and oncology at Festival of Biologics USA 2027

Apr 13–14, 2027 Boston, MA ~2k attendees Website

13 organizations at Festival of Biologics USA 2027 present work in immunotherapy & oncology: 8 drug developers, 3 academic, government and non-profit bodies and 2 suppliers and service providers. Between them they bring 14 presentations to the program. Most represented: Eli Lilly (2 on the program), Genentech (2 on the program), Rondo Therapeutics (2 on the program). As of Oct 15, 2026.

All 126 organizations at Festival of Biologics USA 2027 →

Showing 1–13 of 13 organizations

Organization	Festival of Biologics USA 2027 Attendance
Eli Lilly Indianapolis, IN
lilly.com Large pharma Develops and markets medicines for diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Apr 13 11:00 Antibody discovery against GPCRs & antibodies as tools for small molecule discovery. Antibodies for Immunotherapy Talk Wed Apr 14 14:40 From Propagation to Push-Button: Ready-to-Use Cells and Robotic Liquid Handling in Bioassay QC Lab How frozen ready-to-use cells and pipetting robots make the cell-based tests that check biologic drug batches more consistent and less manual.
Genentech South San Francisco, CA
gene.com Large pharma Biotechnology company in the Roche Group developing medicines for cancer, immunology, neuroscience and other serious diseases.	Talk Tue Apr 13 15:10 Exploring costimulatory receptors CD28 and 4-1BB for cancer immunotherapy Antibodies for Immunotherapy Talk Wed Apr 14 13:20 Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Protein Engineering
Rondo Therapeutics
rondotx.com Biotech Clinical-stage developer of immune cell-engaging bispecific antibodies, including CD28 costimulatory bispecifics, for solid tumors.	Talk Tue Apr 13 13:50 Maximizing the power of bispecific therapies for treating solid tumors Antibodies for Immunotherapy Talk Tue Apr 13 14:30 Engineering CD28-based Costimulatory Bispecific Antibody Platform for the Treatment of Solid Tumors Protein Engineering
3T Biosciences
3tbiosciences.com Biotech Discovers T cell receptor targets on solid tumors and develops TCR-based therapies, including T cell engagers against peptide-HLA targets.	Talk Wed Apr 14 14:00 Developing T cell Engagers Against novel pHLA Targets Oncology
Amsterdam UMC Amsterdam, Netherlands
	Talk Tue Apr 13 12:00 Cancer immunotherapy using bispecific gamma delta T cell engagers Antibodies for Immunotherapy
Dana-Farber Cancer Institute Boston, MA
	Talk Wed Apr 14 11:20 Advances in PD-1 Agonists Oncology
Fred Hutch Cancer Center Seattle, WA
	Talk Wed Apr 14 13:20 Next generation mAbs: new frontiers in cancer treatment Oncology
MB MultiValent Biotherapies Los Altos, CA
Biotech Develops small bivalent peptide-drug conjugates, led by MVB-101 targeting PSMA and folate receptor alpha in prostate cancer.	Talk Wed Apr 14 14:20 Novel ligan-based bispecific drug conjugates targeting prostate cancer Oncology
O OncoResponse
Biotech Develops cancer immunotherapy antibodies, including OR502 against the immune-suppressive receptor LILRB2.	Talk Tue Apr 13 11:40 Development of OR502, in antibody against leukocyte immunoglobulin-like receptor B2, to overcome suppression in the tumor microenvironment Antibodies for Immunotherapy
Seismic Therapeutic Watertown, MA
seismictx.com Biotech Clinical-stage immunology company using machine learning to design biologics for autoimmune, inflammatory and allergic diseases.	Talk Tue Apr 13 14:30 Antibodies for Immunotherapy: title to be announced
Step Pharma Saint-Genis-Pouilly, France
step-ph.com Biotech Clinical-stage biotech developing CTPS1 inhibitors, led by oral dencatistat, for blood cancers and solid tumours.	Talk Wed Apr 14 11:40 A Novel CTPS1 Inhibition Approach Oncology
BPS Bioscience San Diego, CA
bpsbioscience.com Reagents & discovery tools Supplies cell lines, recombinant proteins, assay kits and lentiviruses, plus custom protein expression and screening services, for drug discovery.	Booth Exhibiting (no floor booth listed)
KACTUS
kactusbio.com Reagents & discovery toolsGold sponsor Makes highly active recombinant proteins and enzymes for antibody discovery, immunotherapy, gene therapy and mRNA therapeutics.	Booth Exhibiting (no floor booth listed)